Neumora Therapeutics Receives Nasdaq Minimum Bid Price Notice

Nasdaq notified Neumora Therapeutics that it was not meeting the $1.00 minimum bid price requirement. The company has until April 26, 2027, to regain compliance by maintaining a closing bid of at least $1.00 for 10 consecutive business days.